Category: Tuberculosis
| Intervention | Condition | Outcome / Effect | Source | ||
|---|---|---|---|---|---|
| 📊 |
scale-up of short-course LTBI treatment
vs other LTBI regimens |
Latent Tuberculosis Infection
People |
Four-drug therapy (isoniazid, rifampin, ethambutol, pyrazinamide) was associated with the highest co
15/16 (94%) completed |
↑ |
5614812
up to 4 years |
| 📊 |
short-course LTBI treatment regimens
vs isoniazid monotherapy |
Latent Tuberculosis Infection
People |
Four months of rifampin was associated with higher LTBI treatment completion rates compared to isoni
71% completed |
↑ |
5614812
up to 4 years |
A four-drug short-course therapy for latent tuberculosis infection (LTBI) achieved a 94% completion rate, indicating high adherence compared to traditional regimens. (5614812) Four months of rifampin, a short-course regimen, resulted in a 71% LTBI treatment completion rate, which was higher than isoniazid monotherapy. (5614812)